Top news
Lilly's huge expansion plan took place at record speed to reduce bottlenecks for Mounjaro, Zepbound – Indianapolis ...
By John Russell & Daniel Bradley
Major boost for Zepbound and Mounjaro customers as manufacturer Eli Lily set to ramp up production of...
By Isabelle Hajek
Lilly to Invest Additional $5.3 Billion in Lebanon Research and Innovation District
All coverage
Eli Lilly Plans Indiana Factory Expansion for Sales of Blockbuster Obesity, Diabetes Drugs
By Andy Peters
Holcomb, Eli Lilly announce additional $5.3 billion investment in LEAP • Indiana Capital Chronicle
By Niki Kelly
Lilly announces plans to more than double size of factory in Boone County LEAP district
By Vic Ryckaert
Eli Lilly Makes Largest Manufacturing Investment In Its History To Boost Production For Antidiabetic And Weight Loss ...
By Vandana Singh
Lilly Invests $5.3 Billion to Boost Weight-Loss Drug Supply
By Madison Muller & Isis Almeida
Eli Lilly increases LEAP District investment for weight loss drug
By Binghui Huang & Sarah Bowman
Lilly increases investment to Lebanon manufacturing site to $9B
By Emily Longnecker
Eli Lilly investment in Lebanon up to $9B
By Steve Bittenbender
Lilly to invest $5.3 billion in Indiana to ramp up production of Zepbound, Mounjaro
By Aayushi Pratap
Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply
By Annika Kim Constantino
Lilly invests further $5.3 billion in new Indiana site as obesity drug demand soars
By Patrick Wingrove